Two studies revealed that a new neuroimmunomodulation (NIM) index, which reflects vagal nerve activity (RMSSD) over general systemic inflammation (CRP) significantly predicted the overall survival in patients with advanced PC and in patients with NSCLC. This evidence concerns the gene CRP and non-small cell lung carcinoma.